58198-5448 : Milbemycin Oxime 23 mg / Praziquantel 228 mg Chewable Tablet [Interceptor Plus]


NDC: 58198-5448
Labeler: Elanco Us Inc.
Drug Name: Interceptor Plus
Rev. Date: 


Appearance:


Shapes:  Round
Colors:  Brown
Size (mm): 29
Segments: * 1

* Segments = the number of equally sized pieces which the pill can be broken into. In this case, a value of 1 indicates a solid pill with no score lines.

Active Ingredients:

  • Milbemycin Oxime
  • Praziquantel

Inactive Ingredients:

  • Water
  • Sodium Chloride
  • Propylene Glycol
  • Propyl Gallate
  • Starch, Corn
  • Brown Iron Oxide
  • Glycerin
  • Sucrose
  • Citric Acid Monohydrate
  • Butylated Hydroxyanisole /

Related Products:

Based on records with the same trade name.
  • 58198-5440 Milbemycin Oxime 2.3 mg / Praziquantel 22.8 mg Chewable Tablet [Interceptor Plus] by Elanco Us Inc.
  • 58198-5444 Milbemycin Oxime 5.75 mg / Praziquantel 57 mg Chewable Tablet [Interceptor Plus] by Elanco Us Inc.
  • 58198-5446 Milbemycin Oxime 11.5 mg / Praziquantel 114 mg Chewable Tablet [Interceptor Plus] by Elanco Us Inc.
  • 58198-0702 Interceptor Plus by Novartis Animal Health Us, Inc.
  • 58198-0703 Interceptor Plus by Novartis Animal Health Us, Inc.
  • 58198-0704 Interceptor Plus by Novartis Animal Health Us, Inc.
  • 58198-0705 Interceptor Plus by Novartis Animal Health Us, Inc.

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 58198-5448 QR Code

< Prev: 58198-5446Next: 58198-5451 >

Related Discussions:

Praziquantel not treating Bilhazia
I was diagnosed with Schistosomiasis. Please, I need a total cure for this. I've been taking Praziquantel for years ...




Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.